LAUREN MAYNE: Open Payments
NPI 1851990097 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 28 payments from 10 companies in 2025. Trend: 2023 $95 · 2024 $1,129 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $205 |
| Daiichi Sankyo Inc. | 9 | $173 |
| Legend Biotech USA Inc. | 5 | $98 |
| ABBVIE INC. | 3 | $65 |
| SANOFI-AVENTIS U.S. LLC | 2 | $47 |
| Genentech USA, Inc. | 1 | $21 |
| Genmab U.S., Inc. | 1 | $21 |
| Incyte Corporation | 1 | $20 |
| GENZYME CORPORATION | 1 | $20 |
| Geron Corporation | 1 | $19 |
Products named: CALQUENCE, CARVYKTI, Enhertu, EPKINLY, INJECTAFER, REZUROCK, Vanflyta, Polivy.
Industry payments across OK — which companies pay providers there.
